Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Hofman, Michael S."" wg kryterium: Autor


Tytuł:
The Current Landscape of Prostate-Specific Membrane Antigen (PSMA) Imaging Biomarkers for Aggressive Prostate Cancer.
Autorzy:
Al Saffar, Haidar (AUTHOR)
Chen, David C. (AUTHOR)
Delgado, Carlos (AUTHOR)
Ingvar, Jacob (AUTHOR)
Hofman, Michael S. (AUTHOR)
Lawrentschuk, Nathan (AUTHOR)
Perera, Marlon (AUTHOR)
Murphy, Declan G. (AUTHOR)
Eapen, Renu (AUTHOR)
Pokaż więcej
Źródło:
Cancers. Mar2024, Vol. 16 Issue 5, p939. 17p.
Czasopismo naukowe
Tytuł:
Stereotactic ablative body radiotherapy for primary kidney cancer (TROG 15.03 FASTRACK II): a non-randomised phase 2 trial.
Autorzy:
Siva, Shankar (AUTHOR)
Bressel, Mathias (AUTHOR)
Sidhom, Mark (AUTHOR)
Sridharan, Swetha (AUTHOR)
Vanneste, Ben G L (AUTHOR)
Davey, Ryan (AUTHOR)
Montgomery, Rebecca (AUTHOR)
Ruben, Jeremy (AUTHOR)
Foroudi, Farshad (AUTHOR)
Higgs, Braden (AUTHOR)
Lin, Charles (AUTHOR)
Raman, Avi (AUTHOR)
Hardcastle, Nicholas (AUTHOR)
Hofman, Michael S (AUTHOR)
De Abreu Lourenco, Richard (AUTHOR)
Shaw, Mark (AUTHOR)
Mancuso, Pascal (AUTHOR)
Moon, Daniel (AUTHOR)
Wong, Lih-Ming (AUTHOR)
Lawrentschuk, Nathan (AUTHOR)
Pokaż więcej
Źródło:
Lancet Oncology. Mar2024, Vol. 25 Issue 3, p308-316. 9p.
Czasopismo naukowe
Tytuł:
Corrigendum to “Head-to-head Comparison of the Diagnostic Accuracy of Prostate-specific Membrane Antigen Positron Emission Tomography and Conventional Imaging Modalities for Initial Staging of Intermediate- to High-risk Prostate Cancer: A Systematic Review and Meta-analysis” [Eur. Urol. 84(1) (2023) 36–48]
Autorzy:
Mun Chow, Kit
Zheng So, Wei
Jie Lee, Han
Lee, Alvin
Wei Ting Yap, Dominic
Takwoingi, Yemisi
Jack Tay, Kae
Tuan, Jeffrey
Ping Thang, Sue
Lam, Winnie
Yuen, John
Lawrentschuk, Nathan
Hofman, Michael S.
Murphy, Declan G.
Chen, Kenneth
Pokaż więcej
Źródło:
In European Urology February 2024 85(2):e60-e61
Czasopismo naukowe
Tytuł:
Prostate-specific Membrane Antigen Positron Emission Tomography–detected Disease Extent and Overall Survival of Patients with High-risk Nonmetastatic Castration-resistant Prostate Cancer: An International Multicenter Retrospective Study
Autorzy:
Weber, Manuel
Fendler, Wolfgang P.
Ravi Kumar, Aravind S.
Calais, Jeremie
Czernin, Johannes
Ilhan, Harun
Saad, Fred
Kretschmer, Alexander
Hekimsoy, Turkay
Brookman-May, Sabine D.
Mundle, Suneel D.
Small, Eric J.
Smith, Matthew R.
Perez, Paola M.
Hope, Thomas A.
Herrmann, Ken
Hofman, Michael S.
Eiber, Matthias
Hadaschik, Boris A.
Pokaż więcej
Źródło:
In European Urology January 2024
Czasopismo naukowe
Tytuł:
Clinical Trial Protocol for PRIMARY2: A Multicentre, Phase 3, Randomised Controlled Trial Investigating the Additive Diagnostic Value of [68Ga]Ga-PSMA-11 Positron Emission Tomography/Computed Tomography in Men with Negative or Equivocal Multiparametric Magnetic Resonance Imaging for the Diagnosis of Clinically Significant Prostate Cancer
Autorzy:
Buteau, James P.
Moon, Daniel
Fahey, Michael T.
Roberts, Matthew J.
Thompson, James
Murphy, Declan G.
Papa, Nathan
Mitchell, Catherine
De Abreu Lourenco, Richard
Dhillon, Haryana M.
Kasivisvanathan, Veeru
Francis, Roslyn J.
Stricker, Phillip
Agrawal, Shihka
O'Brien, Jonathan
McVey, Aoife
Sharma, Gaurav
Levy, Sidney
Ayati, Narjess
Nguyen, Andrew
Lee, Su-Faye
Pattison, David A.
Sivaratnam, Dinesh
Frydenberg, Mark
Du, Yang
Titus, Jehan
Lee, Sze-Ting
Ischia, Joseph
Jack, Greg
Hofman, Michael S.
Emmett, Louise
Pokaż więcej
Źródło:
European Urology Oncology; 20240101, Issue: Preprints
Periodyk
Tytuł:
Validation of Prognostic and Predictive Models for Therapeutic Response in Patients Treated with [177Lu]Lu-PSMA-617 Versus Cabazitaxel for Metastatic Castration-resistant Prostate Cancer (TheraP): A Post Hoc Analysis from a Randomised, Open-label, Phase 2 Trial
Autorzy:
Gafita, Andrei
Martin, Andrew J.
Emmett, Louise
Eiber, Matthias
Iravani, Amir
Fendler, Wolfgang P.
Buteau, James
Sandhu, Shahneen
Azad, Arun A.
Herrmann, Ken
Stockler, Martin R.
Davis, Ian D.
Hofman, Michael S.
Pokaż więcej
Źródło:
European Urology Oncology; 20240101, Issue: Preprints
Periodyk
Tytuł:
Detecting localised prostate cancer using radiomic features in PSMA PET and multiparametric MRI for biologically targeted radiation therapy
Autorzy:
Chan, Tsz Him
Haworth, Annette
Wang, AlanAff1, Aff3, Aff4
Osanlouy, Mahyar
Williams, ScottAff5, Aff6
Mitchell, Catherine
Hofman, Michael S.Aff5, Aff8
Hicks, Rodney J.
Murphy, Declan G.
Reynolds, Hayley M.Aff1, IDs13550023009845_cor10
Pokaż więcej
Źródło:
EJNMMI Research. 13(1)
Czasopismo naukowe
Tytuł:
The Dedicated Imaging Post‐Prostatectomy for Enhanced Radiotherapy outcomes (DIPPER) trial protocol: a multicentre, randomised trial of salvage radiotherapy versus surveillance for low‐risk biochemical recurrence after radical prostatectomy.
Autorzy:
Roberts, Matthew J. (AUTHOR)
Conduit, Ciara (AUTHOR)
Davis, Ian D. (AUTHOR)
Effeney, Rachel M. (AUTHOR)
Williams, Scott (AUTHOR)
Martin, Jarad M. (AUTHOR)
Hofman, Michael S. (AUTHOR)
Hruby, George (AUTHOR)
Eapen, Renu (AUTHOR)
Gianacas, Chris (AUTHOR)
Papa, Nathan (AUTHOR)
Lourenço, Richard De Abreu (AUTHOR)
Dhillon, Haryana M. (AUTHOR)
Allen, Ray (AUTHOR)
Fontela, Antoinette (AUTHOR)
Kaur, Baldeep (AUTHOR)
Emmett, Louise (AUTHOR)
Pokaż więcej
Źródło:
BJU International. Aug2023, p1. 9p. 1 Illustration, 3 Charts.
Czasopismo naukowe
Tytuł:
Treatment de‐intensification for low‐risk biochemical recurrence after radical prostatectomy: rational or risky?
Autorzy:
Roberts, Matthew J. (AUTHOR)
Hruby, George (AUTHOR)
Kneebone, Andrew (AUTHOR)
Martin, Jarad M. (AUTHOR)
Williams, Scott G. (AUTHOR)
Frydenberg, Mark (AUTHOR)
Murphy, Declan G. (AUTHOR)
Namdarian, Ben (AUTHOR)
Yaxley, John W. (AUTHOR)
Hofman, Michael S. (AUTHOR)
Davis, Ian D. (AUTHOR)
Emmett, Louise (AUTHOR)
Pokaż więcej
Źródło:
BJU International. Aug2023, Vol. 132 Issue 2, p146-148. 3p.
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies